Back Bay Life Science Advisors

Back Bay Life Science Advisors

Strategic Management Services

Boston, Massachusetts 4,138 followers

Strategic guidance and investment banking for healthcare companies and their investors. DNB//Back Bay Partnership

About us

Back Bay Life Science Advisors offers integrated strategy consulting and investment banking execution for the life sciences. We guide biotech, pharmaceutical, and medical technology companies and their investors on development, commercialization, growth, and maintenance of market share. Back Bay provides clear and unbiased advice and execution for the critical decisions that drive value. In 2023, Back Bay entered a strategic partnership with DNB Bank to provide healthcare companies with strategic guidance, M&A and partnering support and execution and capabilities in global capital markets and investment and commercial banking. Together, as an international collaboration, DNB and Back Bay Life Science Advisors offer unique support to companies along the full continuum of life science and healthcare development. Learn more: https://bit.ly/3MUKD9q

Website
http://BBLSA.com
Industry
Strategic Management Services
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Partnership
Founded
2010
Specialties
Strategy Consulting, Financial Advisory, Biotech, Medical Device , Pharmaceutical , M&A, Cross-border transaction , divestitures, Licensing/partnerships, Franchise , Valuation , Clinical , Scientific , qualitative and quantitative analytics, Early-Stage R&D Strategy, Life cycle management , Product positioning , Corporate Growth Strategy, Exit planning , Market Assessment and Forecasting, Client merger , Client Acquisition, and Investment banking

Locations

  • Primary

    545 Boylston Street

    12th floor

    Boston, Massachusetts 02116, US

    Get directions

Employees at Back Bay Life Science Advisors

Updates

Similar pages

Browse jobs

Funding

Back Bay Life Science Advisors 1 total round

Last Round

Series unknown

US$ 1.6M

See more info on crunchbase